IDiyas

For the Inventor, By the Inventor

Kyoto, Japan

Yoshiaki Aoyagi

USPTO Granted Patents = 24

Average Co-Inventor Count = 5.2

ph-index = 7

Forward Citations = 254(Granted Patents)


Location History:

  • Kyoto, JA (1976)
  • Kyoto, JP (1978 - 1987)
  • Otsu, JP (1982 - 1987)

Company Filing History:

goldMedal24 out of 229 
 
Nippon Shinyaku Company, Ltd.
 patents

Years Active: 1976-1987

Loading Chart...
24 patents (USPTO):Explore Patents
1. 4711898 - 4-quinolone derivatives having anti-inflammatory, anti-allergic, (1987-12-08),
2. 4657907 - Low dosage compositions of finely pulverized (1987-04-14),
3. 4642307 - 1-phenoxy-3-(4-phenylpiperidino)-2-propand having both alpha- and (1987-02-10),
4. 4594345 - Methylflavone-8-carboxylates (1986-06-10),
5. 4533668 - Antihyperglycemic moranoline derivatives (1985-08-06),
6. 4532238 - Finely pulverized 2,4-diamino-6-(2,5-dichloro-phenyl)-1,3,5-triazine and (1985-07-30),
7. 4526894 - Pharmaceutically active 4-hydroxy-3-benzoyl-2-quinolone derivatives (1985-07-02),
8. 4487770 - Treatment of diseases of the liver, kidney, colon and rectum (1984-12-11),
9. 4435397 - Carbamylpiperazine compounds (1984-03-06),
10. 4415570 - Nicotinic acid derivatives (1983-11-15),
11. 4363802 - Moranoline derivatives (1982-12-14),
12. 4339585 - Method for the production of 2-hydroxymethyl-3,4,5-trihydroxy piperidine (1982-07-13),
13. 4338433 - Moranoline derivatives and process for preparation thereof (1982-07-06),
14. 4336374 - Quaternary ammonium substituted N-cinnamylpiperidines (1982-06-22),
15. 4336373 - Bis-piperidine compounds (1982-06-22),

Title: The Innovative Work of Yoshiaki Aoyagi in the Field of Pharmaceuticals

Introduction: Yoshiaki Aoyagi is a notable inventor based in Kyoto, Japan, who has made significant contributions to the pharmaceutical industry. With a remarkable portfolio consisting of 24 patents, Aoyagi has dedicated his career to developing innovative compounds aimed at treating various medical conditions.

Latest Patents: Among his latest patents, Aoyagi has focused on the development of 4-quinolone derivatives which exhibit anti-inflammatory and anti-allergic properties. These compounds are not only useful for their anti-inflammatory, anti-allergenic, antitussive, expectorant, and antithrombotic activities but also open avenues for pharmaceutical compositions that contain these compounds and their acceptable salts. Additionally, Aoyagi has devised low dosage compositions of finely pulverized 2,4-diamino-6-(2,5-dichlorophenyl)-1,3,5-triazine, which has demonstrated effectiveness in treating peptic ulcers when administered to humans in the range of 1 to 4 mg per day.

Career Highlights: Throughout his career, Aoyagi has been affiliated with Nippon Shinyaku Company, Ltd., a leading company in the pharmaceutical sector known for its innovative research and development. His work at the company emphasizes the importance of addressing health issues through scientific advancements, particularly in drug formulations.

Collaborations: Aoyagi collaborates closely with esteemed colleagues such as Hiroshi Enomoto and Shingo Matsumura. Together, they contribute to the research and development of breakthrough pharmaceuticals that assist in treating various ailments and enhancing patient care.

Conclusion: Yoshiaki Aoyagi stands out as an influential inventor whose innovative efforts in the pharmaceutical industry continue to impact the treatment of numerous medical conditions. His dedication to research, along with his collaborations at Nippon Shinyaku Company, Ltd., reinforces the vital role of innovation in advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…